skip to search skip to navigation skip to main content


The number of organ transplantations is increasing every year.

In 2011, more than 30,000 transplants took place in the European Union (EU) alone.1

Astellas is among the global leaders in transplantation, providing immunosuppressant treatments for solid organ transplants such as kidney, liver and heart. Astellas will continue playing a key role in the care of transplant patients. In future, we intend to expand our portfolio beyond immunosuppressant treatments and are currently investigating therapies for prevention of cytomegalovirus infections in transplant patients.

1. European Commission. Organ donation and transplantation. Facts and figures.

Privacy Policy  |  Terms of Use  |  Cookies PolicyCopyright © 2020 Astellas Pharma